Effects of Two Antiretroviral Drugs on the Crustacean <i>Daphnia magna</i> in River Water

Antiretroviral (ARVs) drugs are used to manage the human immunodeficiency virus (HIV) disease and are increasingly being detected in the aquatic environment. However, little is known about their effects on non-target aquatic organisms. Here, <i>Daphnia magna</i> neonates were exposed to...

Full description

Bibliographic Details
Main Authors: Ntombikayise Mahaye, Ndeke Musee
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/10/8/423
Description
Summary:Antiretroviral (ARVs) drugs are used to manage the human immunodeficiency virus (HIV) disease and are increasingly being detected in the aquatic environment. However, little is known about their effects on non-target aquatic organisms. Here, <i>Daphnia magna</i> neonates were exposed to Efavirenz (EFV) and Tenofovir (TFV) ARVs at 62.5–1000 µg/L for 48 h in river water. The endpoints assessed were mortality, immobilization, and biochemical biomarkers (catalase (CAT), glutathione <i>S</i>-transferase (GST), and malondialdehyde (MDA)). No mortality was observed over 48 h. Concentration- and time-dependent immobilization was observed for both ARVs only at 250–1000 µg/L after 48 h, with significant immobilization observed for EFV compared to TFV. Results for biochemical responses demonstrated that both ARVs induced significant changes in CAT and GST activities, and MDA levels, with effects higher for EFV compared to TFV. Biochemical responses were indicative of oxidative stress alterations. Hence, both ARVs could potentially be toxic to <i>D. magna</i>.
ISSN:2305-6304